160 related articles for article (PubMed ID: 29923498)
1. Interactions of methacryloylated gelatin and heparin modulate physico-chemical properties of hydrogels and release of vascular endothelial growth factor.
Claaßen C; Southan A; Grübel J; Tovar GEM; Borchers K
Biomed Mater; 2018 Jul; 13(5):055008. PubMed ID: 29923498
[TBL] [Abstract][Full Text] [Related]
2. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.
Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X
Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840
[TBL] [Abstract][Full Text] [Related]
3. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
4. Gelatin-based hydrogel for vascular endothelial growth factor release in peripheral nerve tissue engineering.
Gnavi S; di Blasio L; Tonda-Turo C; Mancardi A; Primo L; Ciardelli G; Gambarotta G; Geuna S; Perroteau I
J Tissue Eng Regen Med; 2017 Feb; 11(2):459-470. PubMed ID: 24945739
[TBL] [Abstract][Full Text] [Related]
5. Improved vasculogenesis and bone matrix formation through coculture of endothelial cells and stem cells in tissue-specific methacryloyl gelatin-based hydrogels.
Wenz A; Tjoeng I; Schneider I; Kluger PJ; Borchers K
Biotechnol Bioeng; 2018 Oct; 115(10):2643-2653. PubMed ID: 29981277
[TBL] [Abstract][Full Text] [Related]
6. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels.
Janse van Rensburg A; Davies NH; Oosthuysen A; Chokoza C; Zilla P; Bezuidenhout D
Acta Biomater; 2017 Feb; 49():89-100. PubMed ID: 27865963
[TBL] [Abstract][Full Text] [Related]
7. The choice of biopolymer is crucial to trigger angiogenesis with vascular endothelial growth factor releasing coatings.
Claaßen C; Dannecker M; Grübel J; Kotzampasi ME; Tovar GEM; Stanzel BV; Borchers K
J Mater Sci Mater Med; 2020 Oct; 31(11):93. PubMed ID: 33108503
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds.
Patel ZS; Ueda H; Yamamoto M; Tabata Y; Mikos AG
Pharm Res; 2008 Oct; 25(10):2370-8. PubMed ID: 18663411
[TBL] [Abstract][Full Text] [Related]
9. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels.
Peattie RA; Pike DB; Yu B; Cai S; Shu XZ; Prestwich GD; Firpo MA; Fisher RJ
Drug Deliv; 2008 Aug; 15(6):389-97. PubMed ID: 18686083
[TBL] [Abstract][Full Text] [Related]
10. Controlled Release of Vascular Endothelial Growth Factor from Heparin-Functionalized Gelatin Type A and Albumin Hydrogels.
Claaßen C; Sewald L; Tovar GEM; Borchers K
Gels; 2017 Oct; 3(4):. PubMed ID: 30920532
[TBL] [Abstract][Full Text] [Related]
11. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor.
Steffens GC; Yao C; Prével P; Markowicz M; Schenck P; Noah EM; Pallua N
Tissue Eng; 2004; 10(9-10):1502-9. PubMed ID: 15588409
[TBL] [Abstract][Full Text] [Related]
12. Induction of angiogenesis using VEGF releasing genipin-crosslinked electrospun gelatin mats.
Del Gaudio C; Baiguera S; Boieri M; Mazzanti B; Ribatti D; Bianco A; Macchiarini P
Biomaterials; 2013 Oct; 34(31):7754-65. PubMed ID: 23863451
[TBL] [Abstract][Full Text] [Related]
13. Gelatin Matrices for Growth Factor Sequestration.
Buie T; McCune J; Cosgriff-Hernandez E
Trends Biotechnol; 2020 May; 38(5):546-557. PubMed ID: 31954527
[TBL] [Abstract][Full Text] [Related]
14. Beyond the Modification Degree: Impact of Raw Material on Physicochemical Properties of Gelatin Type A and Type B Methacryloyls.
Sewald L; Claaßen C; Götz T; Claaßen MH; Truffault V; Tovar GEM; Southan A; Borchers K
Macromol Biosci; 2018 Dec; 18(12):e1800168. PubMed ID: 30286274
[TBL] [Abstract][Full Text] [Related]
15. Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach.
d'Angelo I; Oliviero O; Ungaro F; Quaglia F; Netti PA
Acta Biomater; 2013 Jul; 9(7):7389-98. PubMed ID: 23523534
[TBL] [Abstract][Full Text] [Related]
16. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.
Zieris A; Prokoph S; Levental KR; Welzel PB; Grimmer M; Freudenberg U; Werner C
Biomaterials; 2010 Nov; 31(31):7985-94. PubMed ID: 20674970
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.
Tan Q; Tang H; Hu J; Hu Y; Zhou X; Tao Y; Wu Z
Int J Nanomedicine; 2011; 6():929-42. PubMed ID: 21720505
[TBL] [Abstract][Full Text] [Related]
18. Covalent Incorporation of Heparin Improves Chondrogenesis in Photocurable Gelatin-Methacryloyl Hydrogels.
Brown GCJ; Lim KS; Farrugia BL; Hooper GJ; Woodfield TBF
Macromol Biosci; 2017 Dec; 17(12):. PubMed ID: 29068543
[TBL] [Abstract][Full Text] [Related]
19. Heparin-conjugated gelatin as a growth factor immobilization scaffold.
Nakamura S; Kubo T; Ijima H
J Biosci Bioeng; 2013 May; 115(5):562-7. PubMed ID: 23273911
[TBL] [Abstract][Full Text] [Related]
20. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels.
Zieris A; Chwalek K; Prokoph S; Levental KR; Welzel PB; Freudenberg U; Werner C
J Control Release; 2011 Nov; 156(1):28-36. PubMed ID: 21763368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
